170 related articles for article (PubMed ID: 37777742)
1. EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance.
de la Peña Avalos B; Tropée R; Duijf PHG; Dray E
Mol Cancer; 2023 Sep; 22(1):158. PubMed ID: 37777742
[TBL] [Abstract][Full Text] [Related]
2. EYA4 drives breast cancer progression and metastasis through its novel role in replication stress avoidance.
de la Peña Avalos B; Tropée R; Duijf PHG; Dray E
Res Sq; 2023 May; ():. PubMed ID: 37292941
[TBL] [Abstract][Full Text] [Related]
3. The protein phosphatase EYA4 promotes homologous recombination (HR) through dephosphorylation of tyrosine 315 on RAD51.
de la Peña Avalos B; Paquet N; Tropée R; Coulombe Y; Palacios H; Leung JW; Masson JY; Duijf PHG; Dray E
Nucleic Acids Res; 2024 Feb; 52(3):1173-1187. PubMed ID: 38084915
[TBL] [Abstract][Full Text] [Related]
4. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
5. The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.
Nelson CB; Rogers S; Roychoudhury K; Tan YS; Atkinson CJ; Sobinoff AP; Tomlinson CG; Hsu A; Lu R; Dray E; Haber M; Fletcher JI; Cesare AJ; Hegde RS; Pickett HA
Nat Commun; 2024 Feb; 15(1):1385. PubMed ID: 38360978
[TBL] [Abstract][Full Text] [Related]
6. Delineating the tumour-regulatory roles of EYA4.
Chong ZX; Ho WY; Yeap SK
Biochem Pharmacol; 2023 Apr; 210():115466. PubMed ID: 36849065
[TBL] [Abstract][Full Text] [Related]
7. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
8. The multi-functional eyes absent proteins.
Hegde RS; Roychoudhury K; Pandey RN
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):372-385. PubMed ID: 32727223
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Luo M; Li Y; Shi X; Yang W; Zhou F; Sun N; He J
Cancer Sci; 2018 Jun; 109(6):1811-1824. PubMed ID: 29660222
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
Miller SJ; Lan ZD; Hardiman A; Wu J; Kordich JJ; Patmore DM; Hegde RS; Cripe TP; Cancelas JA; Collins MH; Ratner N
Oncogene; 2010 Jan; 29(3):368-79. PubMed ID: 19901965
[TBL] [Abstract][Full Text] [Related]
11. EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552.
Zhu XX; Li JH; Cai JP; Hou X; Huang CS; Huang XT; Wang JQ; Li SJ; Xu QC; Yin XY
Cancer Sci; 2019 Oct; 110(10):3110-3121. PubMed ID: 31385398
[TBL] [Abstract][Full Text] [Related]
12. The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.
Pandey RN; Rani R; Yeo EJ; Spencer M; Hu S; Lang RA; Hegde RS
Oncogene; 2010 Jun; 29(25):3715-22. PubMed ID: 20418914
[TBL] [Abstract][Full Text] [Related]
13. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
Roychoudhury K; Hegde RS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920226
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the innate immune response by threonine-phosphatase of Eyes absent.
Okabe Y; Sano T; Nagata S
Nature; 2009 Jul; 460(7254):520-4. PubMed ID: 19561593
[TBL] [Abstract][Full Text] [Related]
15. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
[TBL] [Abstract][Full Text] [Related]
16. EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma.
Li Z; Qiu R; Qiu X; Tian T
Cell Physiol Biochem; 2018; 49(5):1856-1869. PubMed ID: 30231237
[TBL] [Abstract][Full Text] [Related]
17. The Eya phosphatase: Its unique role in cancer.
Zhou H; Zhang L; Vartuli RL; Ford HL; Zhao R
Int J Biochem Cell Biol; 2018 Mar; 96():165-170. PubMed ID: 28887153
[TBL] [Abstract][Full Text] [Related]
18. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
[TBL] [Abstract][Full Text] [Related]
19. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
[TBL] [Abstract][Full Text] [Related]
20. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
Tadjuidje E; Wang TS; Pandey RN; Sumanas S; Lang RA; Hegde RS
PLoS One; 2012; 7(4):e34806. PubMed ID: 22545090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
